DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 115 filers reported holding DENALI THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.32 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,967,704 | -29.3% | 240,800 | +1.1% | 0.00% | -20.0% |
Q2 2023 | $7,026,331 | +48.6% | 238,100 | +16.0% | 0.01% | +66.7% |
Q1 2023 | $4,727,808 | -18.5% | 205,200 | -1.6% | 0.00% | -25.0% |
Q4 2022 | $5,798,385 | -7.4% | 208,500 | +2.2% | 0.00% | 0.0% |
Q3 2022 | $6,264,000 | +5.7% | 204,100 | +1.3% | 0.00% | 0.0% |
Q2 2022 | $5,927,000 | -1.8% | 201,400 | +7.3% | 0.00% | +33.3% |
Q1 2022 | $6,038,000 | -22.1% | 187,700 | +8.1% | 0.00% | -40.0% |
Q4 2021 | $7,747,000 | -11.8% | 173,700 | -0.2% | 0.01% | -16.7% |
Q3 2021 | $8,783,000 | -34.8% | 174,100 | +1.3% | 0.01% | -25.0% |
Q2 2021 | $13,476,000 | +32.5% | 171,800 | -3.5% | 0.01% | +14.3% |
Q1 2021 | $10,170,000 | -30.5% | 178,100 | +1.9% | 0.01% | -30.0% |
Q4 2020 | $14,641,000 | +127.5% | 174,800 | -2.7% | 0.01% | +100.0% |
Q3 2020 | $6,435,000 | +50.8% | 179,600 | +1.8% | 0.01% | +25.0% |
Q2 2020 | $4,268,000 | +101.3% | 176,500 | +45.7% | 0.00% | +100.0% |
Q1 2020 | $2,120,000 | +2.0% | 121,100 | +1.5% | 0.00% | 0.0% |
Q4 2019 | $2,078,000 | +16.6% | 119,300 | +2.6% | 0.00% | 0.0% |
Q3 2019 | $1,782,000 | -25.2% | 116,300 | +1.3% | 0.00% | -33.3% |
Q2 2019 | $2,383,000 | -8.8% | 114,800 | +2.0% | 0.00% | 0.0% |
Q1 2019 | $2,612,000 | +16.0% | 112,500 | +3.2% | 0.00% | 0.0% |
Q4 2018 | $2,252,000 | -3.3% | 109,000 | +1.8% | 0.00% | 0.0% |
Q3 2018 | $2,328,000 | +363.7% | 107,100 | +225.5% | 0.00% | +200.0% |
Q2 2018 | $502,000 | – | 32,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Crestline Management, LP | 5,960,732 | $122,969,901 | 14.32% |
ARCH Venture Management, LLC | 693,749 | $14,312,042 | 9.30% |
Flagship Pioneering Inc. | 2,619,968 | $54,049,940 | 3.92% |
Casdin Capital, LLC | 1,300,000 | $26,819,000 | 2.97% |
Yiheng Capital Management, L.P. | 1,150,684 | $23,738,611 | 1.21% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 154,000 | $3,172,400 | 1.07% |
SECTORAL ASSET MANAGEMENT INC | 254,941 | $5,259,433 | 1.02% |
Temasek Holdings (Private) Ltd | 6,895,992 | $142,264,315 | 0.85% |
Clarius Group, LLC | 378,262 | $7,803,545 | 0.74% |
Artal Group S.A. | 802,899 | $16,564 | 0.71% |